Status:
COMPLETED
Evaluation of Cognitive State in Senior Subjects Using Neurosteer EEG System
Lead Sponsor:
Neurosteer Ltd.
Conditions:
Mild Cognitive Impairment
Eligibility:
All Genders
50+ years
Brief Summary
This is an observational study. Patients who fulfill all inclusion criteria and none of the exclusion criteria will be enrolled in the study, be neurologically evaluated and will go through EEG record...
Detailed Description
One of the major problems in the prevention and treatment of neurological disorders, is the lack of cost effective and reliable tools to assess neurodegeneration on a large scale at a very early stage...
Eligibility Criteria
Inclusion
- Men and women over the age of 50.
- MMSE ≥ 24.
- Patient is able to collaborate.
- No other cognitive comorbidity.
- No seizure events.
Exclusion
- MMSE \< 24.
- Any verbal or non-verbal form of objection from patient or form patient's family member or significant other.
- Presence of several cognitive comorbidity.
- Damage to integrity of scalp and/or skull.
- Skin irritation in the facial and forehead area.
- Significant hearing impairments.
- History of drug abuse.
Key Trial Info
Start Date :
October 15 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2021
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04683835
Start Date
October 15 2020
End Date
October 1 2021
Last Update
November 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dorot - Netanya Geriatric Medical Center
Netanya, Israel, 42420